Literature DB >> 20846731

Effect of topical glucocorticoid treatment in chinchilla model of lipopolysaccharide induced otitis media with effusion.

Charles Pudrith1, You Hyun Kim, Dusan Martin, Amar Gupta, Jared Inman, Rachelle Wareham, Patrick Jahng, You Sun Chung, G Michael Wall, Timothy Jung.   

Abstract

OBJECTIVE: To compare the efficacy of topical treatment with three glucocorticoids in lipopolysaccharide induced otitis media with effusion (OME).
METHODS: Chinchillas were divided into seven treatment groups consisting of vehicle and three glucocorticoids: dexamethasone sodium phosphate (DSP), fluticasone propionate (FP), and hydrocortisone, each at concentrations of 0.1% and 1.0%. LPS (300 μg) was injected into the superior bullae of chinchillas to induce OME. Animals were treated with test substances at -2, 24, and 48 h relative to LPS inoculation. After 96 h, chinchillas were euthanized, samples of middle ear effusion (MEE) were collected, and temporal bones were removed for histopathological examination. Reduction of OME was evaluated by measuring MEE volume and thickness of mucosal lining for each bulla.
RESULTS: One percent treatment of FP significantly reduced MEE. One percent treatment of DSP and HC significantly reduced the mucosal thickness (MT), DSP (15.0 μM) more than HC (30.8 μM). Treatment with 0.1% glucocorticoids did not lead to any significant reduction.
CONCLUSIONS: Clearance of otitis media with effusion seems to be a class effect among glucocorticoids. DSP was the best in reducing MT. It is important to evaluate treatment with various glucocorticoids in order to discover alternative drugs for OME. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846731     DOI: 10.1016/j.ijporl.2010.08.003

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  2 in total

1.  Blocking macrophage migration inhibitory factor activity alleviates mouse acute otitis media in vivo.

Authors:  Jin Zhang; Min Xu; Qingyin Zheng; Yan Zhang; Weijun Ma; Zhaoqiang Zhang
Journal:  Immunol Lett       Date:  2014-08-06       Impact factor: 3.685

Review 2.  Drug-based therapeutic strategies for COVID-19-infected patients and their challenges.

Authors:  Khatereh Zarkesh; Elaheh Entezar-Almahdi; Parisa Ghasemiyeh; Mohsen Akbarian; Marzieh Bahmani; Shahrzad Roudaki; Rahil Fazlinejad; Soliman Mohammadi-Samani; Negar Firouzabadi; Majid Hosseini; Fatemeh Farjadian
Journal:  Future Microbiol       Date:  2021-11-23       Impact factor: 3.165

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.